Emerging Views On Emerging Markets: Bank of America Merrill Lynch Global Healthcare Conference
This article was originally published in PharmAsia News
In this periodic feature, PharmAsia News listens in at major industry events to hear what senior executives have to say about Asia and other emerging markets. In our last profile, we sat in on the recent Morgan Stanley Global Healthcare Conference in New York ('Emerging Views On Emerging Markets: Morgan Stanley Global Healthcare Conference,' PharmAsia News, Sept. 22, 2011). For this profile, we zoom in on the Bank of America Merrill Lynch Global Healthcare Conference, held Sept. 15-16 in London.
You may also be interested in...
Has Roche Set Up Celgene For Success In China?
Celgene is launching Revlimid in China and will go it alone without a local partner. Many consider the move curious, but some say companies such as Roche paved the way for Celgene.
Emerging Views On Emerging Markets: Sanford C. Bernstein & Co. Strategic Decisions Conference
PharmAsia News takes a closer look at presentations by BMS, Celgene, Lilly and Hospira.
Emerging Views On Emerging Markets: JP Morgan Healthcare Conference (Part 1 of 2)
Emerging markets continued to play a large role in company presentations during the industry’s largest investor conference. PharmAsia News takes a closer look.